Phase II study of 4-epirubicin, etoposide and cisplatin as neoadjuvant chemotherapy in locally advanced breast cancer
- 31 December 1994
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (6) , 891
- https://doi.org/10.1016/0959-8049(94)90315-8
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical Research.Journal of Clinical Oncology, 1991
- Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyCancer, 1988
- Management of Locally Advanced Breast CancerAmerican Journal of Clinical Oncology, 1988
- A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group.Journal of Clinical Oncology, 1988
- 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical dataCancer Treatment Reviews, 1983